2021 Q4 Form 10-K Financial Statement

#000165495422003803 Filed on March 25, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2021 2020 Q4

Balance Sheet

Concept 2021 Q4 2021 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $372.6K $372.6K $161.7K
YoY Change 130.36% 130.36% 126.27%
Cash & Equivalents $575.3K $372.6K $350.9K
Short-Term Investments
Other Short-Term Assets $253.1K $253.1K $232.5K
YoY Change 8.86% 8.86% -27.12%
Inventory
Prepaid Expenses
Receivables $80.88K $80.88K $113.9K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $706.5K $706.5K $508.1K
YoY Change 39.05% 39.05% 1.7%
LONG-TERM ASSETS
Property, Plant & Equipment $342.4K $342.4K $512.1K
YoY Change -33.14% -33.14% -27.23%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $342.4K $342.4K $512.1K
YoY Change -33.14% -33.14% -27.79%
TOTAL ASSETS
Total Short-Term Assets $706.5K $706.5K $508.1K
Total Long-Term Assets $342.4K $342.4K $512.1K
Total Assets $1.049M $1.049M $1.020M
YoY Change 2.81% 2.81% -15.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $83.94K $83.94K $155.9K
YoY Change -46.14% -46.14% -35.67%
Accrued Expenses $167.2K $167.2K $433.8K
YoY Change -61.46% -61.46% -78.14%
Deferred Revenue $464.2K $649.8K
YoY Change -28.57%
Short-Term Debt $5.000M $0.00 $5.000M
YoY Change 0.0% 42.12%
Long-Term Debt Due $0.00 $5.000M $423.1K
YoY Change -100.0% 1081.84% -99.06%
Total Short-Term Liabilities $5.872M $5.872M $1.900M
YoY Change 209.02% 209.02% -96.34%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $119.0K
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $282.5K $282.5K $432.1K
YoY Change -34.61% -34.61% -30.55%
Total Long-Term Liabilities $0.00 $282.5K $119.0K
YoY Change -100.0% -95.67% -80.87%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.872M $5.872M $1.900M
Total Long-Term Liabilities $0.00 $282.5K $119.0K
Total Liabilities $6.155M $6.155M $8.423M
YoY Change -26.93% -26.93% -83.96%
SHAREHOLDERS EQUITY
Retained Earnings -$255.3M -$241.2M
YoY Change 5.86%
Common Stock $28.39K $28.39K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$5.106M -$5.106M -$7.403M
YoY Change
Total Liabilities & Shareholders Equity $1.049M $1.049M $1.020M
YoY Change 2.81% 2.81% -15.6%

Cashflow Statement

Concept 2021 Q4 2021 2020 Q4

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 dei Auditor Location
AuditorLocation
Raleigh, North Carolina
CY2021Q4 us-gaap Cash
Cash
372581 USD
CY2020Q4 us-gaap Cash
Cash
161744 USD
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
202761 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
189179 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
0 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
30000 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
80875 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
113906 USD
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
50304 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
43286 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
706521 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
508115 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
342383 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
512124 USD
CY2021Q4 us-gaap Assets
Assets
1048904 USD
CY2020Q4 us-gaap Assets
Assets
1020239 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
83942 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
155850 USD
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
17646 USD
CY2020Q4 us-gaap Interest Payable Current
InterestPayableCurrent
271868 USD
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
156986 USD
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
237750 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
149525 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
161936 USD
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
464162 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
649789 USD
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
423067 USD
CY2021Q4 us-gaap Long Term Loans From Bank
LongTermLoansFromBank
5000000 USD
CY2020Q4 us-gaap Long Term Loans From Bank
LongTermLoansFromBank
0 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5872261 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1900260 USD
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
119033 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
282534 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
432058 USD
CY2021Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 USD
CY2020Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
972108 USD
CY2021Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
0 USD
CY2020Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
5000000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
6154795 USD
CY2020Q4 us-gaap Liabilities
Liabilities
8423459 USD
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q4 most Designated For Series A Convertible Preferred Shares
DesignatedForSeriesAConvertiblePreferredShares
1750000 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1403276 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1166297 shares
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
127162277 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
103649344 USD
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28389493 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28389493 shares
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
28390 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
28390 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
123015819 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
130103361 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-255312377 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-241184315 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-5105891 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-7403220 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1048904 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1020239 USD
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1572884 USD
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1928899 USD
CY2021 most Services And Other
ServicesAndOther
0 USD
CY2020 most Services And Other
ServicesAndOther
-268180 USD
CY2021 us-gaap Revenues
Revenues
1572884 USD
CY2020 us-gaap Revenues
Revenues
2197079 USD
CY2021 most Subscription And Support
SubscriptionAndSupport
742684 USD
CY2020 most Subscription And Support
SubscriptionAndSupport
737783 USD
CY2021 most Services And Other Revenues
ServicesAndOtherRevenues
9000 USD
CY2020 most Services And Other Revenues
ServicesAndOtherRevenues
96162 USD
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
751684 USD
CY2020 us-gaap Cost Of Revenue
CostOfRevenue
833945 USD
CY2021 us-gaap Gross Profit
GrossProfit
821200 USD
CY2020 us-gaap Gross Profit
GrossProfit
1363134 USD
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2134265 USD
CY2020 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1328246 USD
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3531935 USD
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2820222 USD
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2972422 USD
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3325366 USD
CY2021 us-gaap Operating Expenses
OperatingExpenses
8638622 USD
CY2020 us-gaap Operating Expenses
OperatingExpenses
7473834 USD
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-7817422 USD
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-6110700 USD
CY2021 us-gaap Other Income
OtherIncome
904 USD
CY2020 us-gaap Other Income
OtherIncome
95074 USD
CY2021 us-gaap Interest Expense
InterestExpense
290597 USD
CY2020 us-gaap Interest Expense
InterestExpense
6040630 USD
CY2021 most Gains Losses On Extinguishment Of Debt Other
GainsLossesOnExtinguishmentOfDebtOther
1084100 USD
CY2020 most Gains Losses On Extinguishment Of Debt Other
GainsLossesOnExtinguishmentOfDebtOther
0 USD
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
7114422 USD
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
59353584 USD
CY2021 us-gaap Other Nonoperating Gains Losses
OtherNonoperatingGainsLosses
9375 USD
CY2020 us-gaap Other Nonoperating Gains Losses
OtherNonoperatingGainsLosses
0 USD
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6310640 USD
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-65299140 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-14128062 USD
CY2021 most Dividend On Series A Convertible Preferred Stock
DividendOnSeriesAConvertiblePreferredStock
-10315099 USD
CY2020 most Dividend On Series A Convertible Preferred Stock
DividendOnSeriesAConvertiblePreferredStock
0 USD
CY2021 most Deemed Dividends Preferred Stock Stock
DeemedDividendsPreferredStockStock
-10031415 USD
CY2020 most Deemed Dividends Preferred Stock Stock
DeemedDividendsPreferredStockStock
-37438180 USD
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-34474576 USD
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-108848020 USD
CY2021 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-1.21
CY2020 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-3.83
CY2021 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
28389493 shares
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
28389493 shares
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-14128062 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-71409840 USD
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
0 USD
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
34838 USD
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 USD
CY2020 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
30000 USD
CY2021 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
78119 USD
CY2020 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
3184641 USD
CY2021 most Amortization Of Debt Discount Premiums
AmortizationOfDebtDiscountPremiums
0 USD
CY2020 most Amortization Of Debt Discount Premiums
AmortizationOfDebtDiscountPremiums
-1218824 USD
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
3227557 USD
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
3109763 USD
CY2021 most Gain Of Debt Extinguishment Ppp Loan Forgiveness
GainOfDebtExtinguishmentPppLoanForgiveness
1084100 USD
CY2020 most Gain Of Debt Extinguishment Ppp Loan Forgiveness
GainOfDebtExtinguishmentPppLoanForgiveness
0 USD
CY2021 most Losses On Debt Extinguishments
LossesOnDebtExtinguishments
-7114422 USD
CY2020 most Losses On Debt Extinguishments
LossesOnDebtExtinguishments
-59353584 USD
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-33031 USD
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-34719 USD
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
7018 USD
CY2020 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-32203 USD
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-71908 USD
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-86399 USD
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-185627 USD
CY2020 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-429582 USD
CY2021 most Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
169741 USD
CY2020 most Beneficial Conversion Feature Recorded As A Result Of Issuance Of Convertible Debt
BeneficialConversionFeatureRecordedAsAResultOfIssuanceOfConvertibleDebt
8404858 USD
CY2020 most Exchange Of Debt For Series A Convertible Preferred Shares Amount
ExchangeOfDebtForSeriesAConvertiblePreferredSharesAmount
103299344 USD
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
350000 USD
CY2020 most Beneficial Conversion Feature Recorded
BeneficialConversionFeatureRecorded
0 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-71409840 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-7403220 USD
CY2021 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
3227557 USD
CY2020 most Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
162214 USD
CY2021 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-161935 USD
CY2020 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-149525 USD
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-63501 USD
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
111880 USD
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5079281 USD
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7309766 USD
CY2021 us-gaap Proceeds From Issuance Of Subordinated Long Term Debt
ProceedsFromIssuanceOfSubordinatedLongTermDebt
0 USD
CY2020 us-gaap Proceeds From Issuance Of Subordinated Long Term Debt
ProceedsFromIssuanceOfSubordinatedLongTermDebt
1910000 USD
CY2021 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 USD
CY2020 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1650000 USD
CY2021 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
CY2020 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
2900000 USD
CY2021 us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
0 USD
CY2020 us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
6378 USD
CY2021 us-gaap Proceeds From Loan Originations1
ProceedsFromLoanOriginations1
0 USD
CY2020 us-gaap Proceeds From Loan Originations1
ProceedsFromLoanOriginations1
542100 USD
CY2021 us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
542000 USD
CY2020 us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
0 USD
CY2021 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
4761700 USD
CY2020 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
350000 USD
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5303700 USD
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7345722 USD
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
224419 USD
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
35956 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
314967 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
575342 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
350923 USD
CY2021 most Cash And Cash Equivalents
CashAndCashEquivalents
372581 USD
CY2020 most Cash And Cash Equivalents
CashAndCashEquivalents
161744 USD
CY2021 most Restricteds Cash
RestrictedsCash
202761 USD
CY2020 most Restricteds Cash
RestrictedsCash
189179 USD
CY2021 most Total Cash Cash Equivalents And Restricted Cash
TotalCashCashEquivalentsAndRestrictedCash
575342 USD
CY2020 most Total Cash Cash Equivalents And Restricted Cash
TotalCashCashEquivalentsAndRestrictedCash
350923 USD
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
205243 USD
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
191805 USD
CY2021 us-gaap Interest Paid Net
InterestPaidNet
146514 USD
CY2020 us-gaap Interest Paid Net
InterestPaidNet
3919183 USD
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
CY2021 most Recorded Debt Discount Associated With Beneficial Conversion Feature
RecordedDebtDiscountAssociatedWithBeneficialConversionFeature
0 USD
CY2020 most Recorded Debt Discount Associated With Beneficial Conversion Feature
RecordedDebtDiscountAssociatedWithBeneficialConversionFeature
8404858 USD
CY2021 most Recorded Discount Associated With Beneficial Conversion Feature On Issuance Of Series A Convertible Preferred Shares
RecordedDiscountAssociatedWithBeneficialConversionFeatureOnIssuanceOfSeriesAConvertiblePreferredShares
10031415 USD
CY2020 most Recorded Discount Associated With Beneficial Conversion Feature On Issuance Of Series A Convertible Preferred Shares
RecordedDiscountAssociatedWithBeneficialConversionFeatureOnIssuanceOfSeriesAConvertiblePreferredShares
37438180 USD
CY2021 most Preferred Stock Issued During Period Exchange For Carrying Value Of Debt Value
PreferredStockIssuedDuringPeriodExchangeForCarryingValueOfDebtValue
6507137 USD
CY2020 most Preferred Stock Issued During Period Exchange For Carrying Value Of Debt Value
PreferredStockIssuedDuringPeriodExchangeForCarryingValueOfDebtValue
103299344 USD
CY2021 most Issued Shares Of Series A Preferred Shares Fair Valued As Dividend Paid In Kind
IssuedSharesOfSeriesAPreferredSharesFairValuedAsDividendPaidInKind
10315099 USD
CY2020 most Issued Shares Of Series A Preferred Shares Fair Valued As Dividend Paid In Kind
IssuedSharesOfSeriesAPreferredSharesFairValuedAsDividendPaidInKind
0 USD
CY2021 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
361866 USD
CY2020 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
0 USD
CY2021 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 USD
CY2020 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
156980 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-51314325 USD
CY2020 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
3109763 USD
CY2020 most Conversion Of Notes Payable To Common Stock Amount
ConversionOfNotesPayableToCommonStockAmount
156980 USD
CY2021 most Exchange Of Debt For Series A Convertible Preferred Shares Amount
ExchangeOfDebtForSeriesAConvertiblePreferredSharesAmount
7660970 USD
CY2021 most Issuance Of Series A Convertible Preferred Shares For Cash Amount
IssuanceOfSeriesAConvertiblePreferredSharesForCashAmount
4761700 USD
CY2021 most Preferred Shares To Settle Accrued And Unpaid Interest Amount
PreferredSharesToSettleAccruedAndUnpaidInterestAmount
775164 USD
CY2021 most Stockissueddividend On Series A Convertible Preferred Shares Amount
StockissueddividendOnSeriesAConvertiblePreferredSharesAmount
0 USD
CY2021 most Beneficial Conversion Feature Recorded As A Result Of Issuance Of Series A Convertible Preferred Shares Of5269401
BeneficialConversionFeatureRecordedAsAResultOfIssuanceOfSeriesAConvertiblePreferredSharesOf5269401
10031415 USD
CY2021 most Deemed Dividend To The Holders Of Series A Preferred Shares Resulting From Amortization Of Discount Associated With The Beneficial Conversion Feature
DeemedDividendToTheHoldersOfSeriesAPreferredSharesResultingFromAmortizationOfDiscountAssociatedWithTheBeneficialConversionFeature
-10031415 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-14128062 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-5105891 USD
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States (“US GAAP”) requires management to make estimates and assumptions in the Company’s financial statements and notes thereto. Significant estimates and assumptions made by management include the determination of performance obligations and the allocation of consideration among performance obligations, and the determination of when the Company has met the requirements to recognize revenue related to the performance obligations, share-based compensation and allowance for accounts receivable. Actual results could differ from those estimates.</p>
CY2021 most Htt
htt
250000 USD
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Most of the Company’s receivables (billings) are collected within 30-45 days. The majority of the Company’s customers are healthcare organizations, which historically have had low credit risk. </p>
CY2021 us-gaap Advertising Expense
AdvertisingExpense
267884 USD
CY2020 us-gaap Advertising Expense
AdvertisingExpense
248261 USD
CY2021Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
5000000 USD
CY2020Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
6514208 USD
CY2021Q4 us-gaap Debt Current
DebtCurrent
5000000 USD
CY2020Q4 us-gaap Debt Current
DebtCurrent
423067 USD
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
6091141 USD
CY2020Q4 us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
1694467 USD
CY2021 us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
6507137 USD
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28389493 shares
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 most Authorized To Designate Preferred Stock
AuthorizedToDesignatePreferredStock
1750000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021 most Annual Dividend
AnnualDividend
3.43
CY2021 most Effective Yield
EffectiveYield
0.08 pure
CY2021 us-gaap Conversion Of Stock Description
ConversionOfStockDescription
Holder into 30 shares of common stock, which results in conversion ratio of $1.43 of stated
CY2020Q4 most Preferred Stock Share Issued
PreferredStockShareIssued
1158141 shares
CY2021 us-gaap Convertible Preferred Dividends Net Of Tax
ConvertiblePreferredDividendsNetOfTax
103299344 USD
CY2020Q4 most Conversions Price
ConversionsPrice
1.43
CY2019 most Debt Exchange
DebtExchange
37176330 USD
CY2021Q1 most Preferred Stock Share Issued
PreferredStockShareIssued
70014 shares
CY2021Q1 most Conversions Price
ConversionsPrice
1.43
CY2021 most Debt Exchange
DebtExchange
3507701 USD
CY2020Q4 most Preferred Stock Share Issued
PreferredStockShareIssued
8156 shares
CY2020Q4 most Cash Funding
CashFunding
350000 USD
CY2020Q4 most Loss Attributable To Common Shareholders
LossAttributableToCommonShareholders
261850 USD
CY2021Q4 most Preferred Stock Share Issued
PreferredStockShareIssued
110996 shares
CY2021Q4 most Cash Funding
CashFunding
4761700 USD
CY2021Q4 most Loss Attributable To Common Shareholders
LossAttributableToCommonShareholders
3887573 USD
CY2021Q3 most Preferred Stock Share Issued
PreferredStockShareIssued
55969 shares
CY2021Q3 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
167000 USD
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55969 shares
CY2021Q3 most Issued As Paid In Kind Dividends
IssuedAsPaidInKindDividends
52057 shares
CY2021Q3 most Cash Funding98
CashFunding98
10315099 USD
CY2021Q3 most Conversions Price
ConversionsPrice
1.43
CY2021Q3 most Loss Attributable To Common Shareholders
LossAttributableToCommonShareholders
2451888 USD
CY2021Q4 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
775164 USD
CY2021Q4 most Cash Funding98
CashFunding98
184616 USD
CY2016Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15000000 shares
CY2016Q2 us-gaap Conversion Of Stock Description
ConversionOfStockDescription
exercise price of not less than 110% of the fair market value of the common stock on the date the option is granted. Incentive stock options typically have a maximum term of 10 years, except for option grants to 10% stockholders
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
12345796 shares
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
1.73
CY2020 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P8Y3M18D
CY2020 most Aggregate Intrinsic Value Outstanding Beginning
AggregateIntrinsicValueOutstandingBeginning
13823410 USD
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
3102496 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.73
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1440000 shares
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.64
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10683300 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.85
CY2021 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P7Y7M6D
CY2020 most Aggregate Intrinsic Value Outstanding End
AggregateIntrinsicValueOutstandingEnd
17060533 USD
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
2439000 shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
1.82
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2639000 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.70
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10883300 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.06
CY2021 most Aggregate Intrinsic Value Outstanding End
AggregateIntrinsicValueOutstandingEnd
9553832 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
5729750 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
1.89
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
6013566 USD
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.70
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.27
CY2021Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
8540483 USD
CY2021Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
1.63
CY2020Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
3.97
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000 pure
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.72 pure
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.15 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.010 pure
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.004 pure
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y6M
CY2020Q1 us-gaap Financial Guarantee Insurance Contracts Claim Liability Weighted Average Risk Free Discount Rate
FinancialGuaranteeInsuranceContractsClaimLiabilityWeightedAverageRiskFreeDiscountRate
0.0250 pure
CY2020Q1 us-gaap Accelerated Share Repurchases Final Price Paid Per Share
AcceleratedShareRepurchasesFinalPricePaidPerShare
1.23
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.80 pure
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P15Y
CY2021Q1 us-gaap Accelerated Share Repurchases Final Price Paid Per Share
AcceleratedShareRepurchasesFinalPricePaidPerShare
3.10
CY2021Q1 us-gaap Financial Guarantee Insurance Contracts Claim Liability Weighted Average Risk Free Discount Rate
FinancialGuaranteeInsuranceContractsClaimLiabilityWeightedAverageRiskFreeDiscountRate
0.0135 pure
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.80 pure
CY2021Q3 us-gaap Financial Guarantee Insurance Contracts Claim Liability Weighted Average Risk Free Discount Rate
FinancialGuaranteeInsuranceContractsClaimLiabilityWeightedAverageRiskFreeDiscountRate
0.0158 pure
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P15Y
CY2021Q3 most Percent Of Probability Of Payment Of Dividend Increased
PercentOfProbabilityOfPaymentOfDividendIncreased
0.90 pure
CY2021Q3 most Percent Ofp Pobability Of Dividend Paid In Cash Reduced
PercentOfpPobabilityOfDividendPaidInCashReduced
0.10 pure
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
0 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
5000 USD
CY2021Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
8000 USD
CY2020Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
84000 USD
CY2021Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
0 USD
CY2020Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
41000 USD
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
0 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
53000 USD
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
22384000 USD
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
21433000 USD
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
22392000 USD
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
21606000 USD
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
22392000 USD
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
21606000 USD
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-2966893 USD
us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-14996067 USD
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-169537 USD
us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-856918 USD
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
716518 USD
us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
690367 USD
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Amortization
IncomeTaxReconciliationNondeductibleExpenseAmortization
17343 USD
us-gaap Income Tax Reconciliation Nondeductible Expense Amortization
IncomeTaxReconciliationNondeductibleExpenseAmortization
436411 USD
CY2021 most Income Tax Reconciliation Expiration Of Net Operating Losses
IncomeTaxReconciliationExpirationOfNetOperatingLosses
2726000 USD
CY2021 most Income Tax Reconciliation Nondeductible Expense Gain Loss On Debt Extinguishment
IncomeTaxReconciliationNondeductibleExpenseGainLossOnDebtExtinguishment
1336650 USD
most Income Tax Reconciliation Nondeductible Expense Gain Loss On Debt Extinguishment
IncomeTaxReconciliationNondeductibleExpenseGainLossOnDebtExtinguishment
13176496 USD
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
-6288 USD
us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
145036 USD
most Income Tax Reconciliation Expiration Of Net Operating Losses
IncomeTaxReconciliationExpirationOfNetOperatingLosses
286207 USD
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
786000 USD
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-1321325 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021 us-gaap Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
As of December 31, 2021, the Company had U.S. federal net operating loss (“NOL”) carryforwards of approximately $100.0 million, of which $24.1 million will never expire and approximately $76 million will expire between 2022 and 2039. For state tax purposes, the NOL carryforwards expire between 2022 and 2034
CY2021 most Equity Ownership
EquityOwnership
0.50 pure
CY2021 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
48000 USD
CY2020 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
34000 USD
CY2021Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
1384878 USD
CY2021 us-gaap Revenues
Revenues
1572884 USD
CY2020Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
1825416 USD
CY2020 us-gaap Revenues
Revenues
2197079 USD
CY2021Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
1384878 USD
CY2021 us-gaap Revenues
Revenues
1572884 USD
CY2020Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
1825416 USD
CY2020 us-gaap Revenues
Revenues
2197079 USD
CY2021Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
861686 USD
CY2021Q4 most Recognition Of Revenue From The Unsatisfied Performance Obligations In Year Two
RecognitionOfRevenueFromTheUnsatisfiedPerformanceObligationsInYearTwo
623469 USD
CY2021Q4 most Recognition Of Revenue From The Unsatisfied Performance Obligations In Year Three
RecognitionOfRevenueFromTheUnsatisfiedPerformanceObligationsInYearThree
188914 USD
CY2021Q4 most Recognition Of Revenue From The Unsatisfied Performance Obligations In Current Year
RecognitionOfRevenueFromTheUnsatisfiedPerformanceObligationsInCurrentYear
49303 USD
CY2021Q4 most Contract Liability Net
ContractLiabilityNet
861686 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
649789 USD
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
205243 USD
CY2021 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P2Y3M18D
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.08 pure
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
205170 USD
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
205593 USD
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
68531 USD
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
479294 USD
CY2021Q4 most Imputed Interest
ImputedInterest
-47235 USD
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
432059 USD

Files In Submission

Name View Source Status
0001654954-22-003803-index-headers.html Edgar Link pending
0001654954-22-003803-index.html Edgar Link pending
0001654954-22-003803.txt Edgar Link pending
0001654954-22-003803-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
most-20211231.xsd Edgar Link pending
most-20211231_cal.xml Edgar Link unprocessable
most-20211231_def.xml Edgar Link unprocessable
most-20211231_lab.xml Edgar Link unprocessable
most-20211231_pre.xml Edgar Link unprocessable
most_10k.htm Edgar Link pending
most_10k_htm.xml Edgar Link completed
most_ex231.htm Edgar Link pending
most_ex311.htm Edgar Link pending
most_ex312.htm Edgar Link pending
most_ex321.htm Edgar Link pending
most_ex322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending